Page last updated: 2024-08-16

triazolam and caffeine

triazolam has been researched along with caffeine in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's7 (35.00)18.2507
2000's9 (45.00)29.6817
2010's3 (15.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Mattila, ME; Mattila, MJ; Nuotto, E1
Bickel, WK; Fenwick, JW; Higgins, ST; Hughes, JR; Oliveto, AH; Shea, PJ1
Freeman, CR; Gomez, SA; Johnson, LC; Spinweber, CL1
Roehrs, T; Roth, T; Smith, D; Zorick, F; Zwyghuizen-Doorenbos, A1
Goldman, NH; Madakasira, S; Rowlett, JK; Rush, CR; Woolverton, WL1
Badger, GJ; Bickel, WK; Hughes, JR; Kamien, JB; Smith, BJ1
Badger, G; Bickel, WK; Higgins, ST; Hughes, JR; Oliveto, AH1
Bickel, WK; Smith, BJ2
Baker, RW; Rowlett, JK; Rush, CR1

Reviews

1 review(s) available for triazolam and caffeine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

7 trial(s) available for triazolam and caffeine

ArticleYear
Caffeine moderately antagonizes the effects of triazolam and zopiclone on the psychomotor performance of healthy subjects.
    Pharmacology & toxicology, 1992, Volume: 70, Issue:4

    Topics: Anti-Anxiety Agents; Azabicyclo Compounds; Caffeine; Double-Blind Method; Humans; Piperazines; Psychomotor Performance; Reference Values; Triazolam

1992
Reversal by caffeine of triazolam-induced impairment of waking function.
    Psychopharmacology series, 1988, Volume: 6

    Topics: Adult; Arousal; Caffeine; Humans; Hypnotics and Sedatives; Male; Memory; Psychomotor Performance; Sleep; Triazolam; Wakefulness

1988
Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:1

    Topics: Adult; Caffeine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pentobarbital; Pyridines; Triazolam; Zolpidem

1997
Secobarbital in humans discriminating triazolam under two-response and novel-response procedures.
    Pharmacology, biochemistry, and behavior, 1997, Volume: 58, Issue:4

    Topics: Adult; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Secobarbital; Triazolam

1997
Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
    Behavioural pharmacology, 1997, Volume: 8, Issue:2-3

    Topics: Adult; Anti-Anxiety Agents; Buspirone; Caffeine; Central Nervous System Stimulants; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Generalization, Stimulus; Humans; Hypnotics and Sedatives; Male; Psychomotor Performance; Triazolam

1997
Flumazenil discrimination by humans under a two-response and a novel-response procedure.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3

    Topics: Adolescent; Adult; Caffeine; Central Nervous System Stimulants; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Modulators; Humans; Male; Midazolam; Psychomotor Performance; Triazolam

1999
Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Experimental and clinical psychopharmacology, 2000, Volume: 8, Issue:1

    Topics: Adult; Caffeine; Central Nervous System Stimulants; Cues; Discrimination Learning; Discrimination, Psychological; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Pentobarbital; Psychomotor Performance; Pyridines; Surveys and Questionnaires; Triazolam; Zolpidem

2000

Other Studies

12 other study(ies) available for triazolam and caffeine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 261, Issue:3

    Topics: Adult; Caffeine; Discrimination Learning; Female; Humans; Male; Microcomputers; Psychomotor Performance; Reaction Time; Triazolam

1992
Subjective and objective measures of sleepiness: effect of benzodiazepine and caffeine on their relationship.
    Psychophysiology, 1991, Volume: 28, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Caffeine; Double-Blind Method; Electrocardiography; Electroencephalography; Electrooculography; Flurazepam; Humans; Male; Sleep; Sleep, REM; Triazolam

1991
Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
    Drug and alcohol dependence, 2001, Feb-01, Volume: 61, Issue:3

    Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Caffeine; Discrimination, Psychological; Female; GABA Agonists; GABA Modulators; Humans; Male; Phosphodiesterase Inhibitors; Pyridines; Triazolam; Zolpidem

2001
[Strategies against jet lag].
    Praxis, 2004, Apr-21, Volume: 93, Issue:17

    Topics: Anti-Anxiety Agents; Caffeine; Central Nervous System Stimulants; Complementary Therapies; Homeopathy; Humans; Jet Lag Syndrome; Melatonin; Time Factors; Triazolam

2004